Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
Roswell Park Cancer Institute
Instituto de Investigación Biomédica de Salamanca
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
University of Michigan Rogel Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
New York Medical College
New York Medical College
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Nantes University Hospital
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Fondazione Italiana Linfomi - ETS
Comenius University
Beijing Tongren Hospital
Sykehuset Innlandet HF
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Noordwest Ziekenhuisgroep
Yale University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Utah